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Abstract
Although often clinically indistinguishable in the early stages, Parkinson’s disease (PD), Multiple System Atrophy (MSA) and
Progressive Supranuclear Palsy (PSP) have distinct neuropathological changes. The aim of the current study was to identify
white matter tract neurodegeneration characteristic of each of the three syndromes. Tract-based spatial statistics (TBSS) was
used to perform a whole-brain automated analysis of diffusion tensor imaging (DTI) data to compare differences in
fractional anisotropy (FA) and mean diffusivity (MD) between the three clinical groups and healthy control subjects. Further
analyses were conducted to assess the relationship between these putative indices of white matter microstructure and
clinical measures of disease severity and symptoms. In PSP, relative to controls, changes in DTI indices consistent with white
matter tract degeneration were identified in the corpus callosum, corona radiata, corticospinal tract, superior longitudinal
fasciculus, anterior thalamic radiation, superior cerebellar peduncle, medial lemniscus, retrolenticular and anterior limb of
the internal capsule, cerebral peduncle and external capsule bilaterally, as well as the left posterior limb of the internal
capsule and the right posterior thalamic radiation. MSA patients also displayed differences in the body of the corpus
callosum corticospinal tract, cerebellar peduncle, medial lemniscus, anterior and superior corona radiata, posterior limb of
the internal capsule external capsule and cerebral peduncle bilaterally, as well as the left anterior limb of the internal
capsule and the left anterior thalamic radiation. No significant white matter abnormalities were observed in the PD group.
Across groups, MD correlated positively with disease severity in all major white matter tracts. These results show widespread
changes in white matter tracts in both PSP and MSA patients, even at a mid-point in the disease process, which are not
found in patients with PD.
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Introduction
Parkinson’s disease (PD), Multiple System Atrophy (MSA) and
Progressive Supranuclear Palsy (PSP) are neurodegenerative
diseases that are characterized by very similar motor symptoms,
making them difficult to distinguish in the early stages [1,2],
despite having distinct molecular pathology [3–5].
A range of Magnetic Resonance Imaging (MRI) techniques
have been used to identify regions of brain pathology in
parkinsonian syndromes. Previous imaging studies have highlight-
ed pathological changes in white matter, with some involvement of
the cortex [6–10]. Diffusion tensor imaging (DTI) provides an
indirect insight into white matter microstructure in disease [11].
Frequently used DTI measures include fractional anisotropy (FA)
(directionality of water molecule movement within white matter
fibers and axons) and mean diffusivity (MD) (degree to which
water molecules move within tissues). Studies utilising FA, MD
and other diffusion measures in PSP have described abnormalities
in the superior longitudinal fasciculus, corpus callosum [12,13]
and superior cerebellar peduncles [13–17], whilst in MSA white
matter abnormalities have been identified in the putamen [8] and
middle cerebellar peduncles [18,19]. In non-demented PD, white
matter is thought to remain largely normal [20], however there
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have been reports of corpus callosum, superior cerebellar
peduncles, cingulum and uncinate involvement [17].
Previous neuroimaging studies have often taken a Region of
Interest (ROI) approach and few DTI studies have been carried
out to characterize the whole brain white matter pathology of
patients with Parkinson’s Plus syndromes. Tract-Based Spatial
Statistics (TBSS) is a whole-brain skeleton-based technique [21]
that enables differences in measures such as FA and MD, that may
reflect the microstructural properties of white matter tracts, to be
identified, whilst avoiding the need for a priori regions of interest
to be selected. TBSS also offers advantages over standard voxel-
based analytic techniques by removing the need for spatial
smoothing and minimizing the methodological pitfalls caused by
misalignment and misregistration, consequently increasing the
sensitivity and interpretability of findings.
The present study aimed to use TBSS to compare FA and MD
values across PSP, MSA, PD and healthy controls, enabling the
characterization of regions of abnormal white matter diffusion
properties. We performed a series of analyses to test the hypothesis
that white matter changes are present in the superior cerebellar
peduncle, superior longitudinal fasciculus and corpus callosum in
PSP, middle cerebellar peduncles and motor tracts in MSA, with
fewer changes demonstrated in the PD group. To our knowledge
this is the first study to assess PD, MSA, PSP and healthy controls
in a single study using a whole brain approach.
Methods
Participants
Sixteen patients diagnosed with the Richardson’s syndrome
variant of PSP, seventeen with MSA and fourteen with PD,
according to established criteria, [22–24] were recruited succes-
sively from the Movement Disorders Clinic at King’s College
Hospital and via referrals from clinicians in south east England.
Both clinical variants of MSA were included; eleven probable
MSA-P (predominant parkinsonian features) and five MSA-C
(predominant cerebellar features). All PSP patients were classified
as probable, [1] while all patients with PD fulfilled criteria for
definite PD [23]. Eighteen healthy age-matched controls were also
recruited (spouses and friends of patients) (see Table 1).
Ethics Statement
The project was approved by research ethics committees of
King’s Healthcare NHS Trust and the Institute of Psychiatry and
South London and Maudsley NHS Trust. Written informed
consent was given by all subjects before participation in the study.
Clinical and cognitive measures
Within 1 week of the MRI scan each participant was examined
by the same clinician (CB). Disease severity was measured using
Hoehn and Yahr (H&Y) [25], Schwab and England Activities of
Daily Living (ADL) [26] and Unified Parkinson’s Disease Rating
Scale Part III (UPDRS-III) [27]. Cerebellar ataxia and occulo-
motor dysfunction were assessed using the Parkinson’s Plus Scale
(PPS) [28]. A higher score on the UPDRS-III (0–108 points) and
H&Y (stages 1–5) represents greater impairment, whilst a higher
score on the Schwab and England ADL (0–100%) represents less
impairment. Global cognitive function was assessed using the
Mini-Mental State Examination (MMSE) [29] and Mattis
Dementia Rating Scale (DRS) [30].
Image acquisition
All images were acquired with slices parallel to the anterior
commissure–posterior commissure line, on a 1.5-T Signa LX NV/
i system (General Electric, Milwaukee, WI), with actively shielded
magnetic field gradients (maximum amplitude 40 mTm21). A
standard quadrature birdcage head coil was used for both RF
transmission and reception.
Using a multislice, peripherally gated echoplanar imaging pulse
sequence, each DTI volume was acquired from 60 contiguous
2.5 mm thick slices with field of view (FOV) 2406240 mm and
matrix size 96696, zero-filled to 1286128, giving an in-plane
voxel size of 1.87561.875 mm2. Echo time was 107 ms, and
effective repetition time was 15 R-R intervals. At each location, 7
images were acquired without diffusion weighting, together with
64 images with a weighting of 1,300 s mm22 applied along
directions uniformly distributed in space (Jones et al, 2002). Since
acquisition of DTI data were cardiac-gated, scanning time varied
according to each subjects pulse rate. For most subjects, scanning
time was approximately 25 minutes. A semi-automated EPI
quality control procedure was used [31].
Image processing
An additional visual inspection of diffusion data was further
used to exclude data that did not meet quality requirements; one
MSA patient and one healthy control subject were excluded due to
corrupted scans. Data were then processed using ExploreDTI [32]
to correct for the effects of eddy current distortions and head
motion. For each subject the b-matrix was then re-oriented to
provide a more accurate estimate of tensor orientations. The
diffusion-tensor was estimated using a non-linear least square
approach, with FA and MD calculated from the diffusion-tensor.
Voxel-wise statistical analysis of FA and MD was carried out using
TBSS v1.2 (tract-based spatial statistics) (http://www.fmrib.ox.ac.
uk/fsl/tbss/) [21,33,34] to compare groups. First, each fractional
anisotropy image was registered to standard MNI space using the
non-linear registration tool in FSL (FNIRT), resulting in a
standardised version of each FA image. These steps were repeated
for the mean diffusivity data. A voxel-wise average of all subjects
was used to create a study-specific mean fractional anisotropy
image, which was then ‘skeletonized’ to create a mean fractional
anisotropy skeleton, representing the centres of all white matter
tracts. To exclude low anisotropic regions in the skeleton, a
fractional anisotropy threshold of 0.2 was applied.
Statistical Analysis
Clinical Variables. Clinical variables were analysed using
SPSS (version 20); one-way ANOVA with built-in post-hoc
Bonferroni tests were used to assess between-group differences in
age, duration of disease, UPDRS-III and cognitive measures
(MMSE and DRS scores). Post-hoc t-tests were also performed to
assess the difference in age between the PSP group and each other
group.
A Kruskall-Wallis test was run to determine if there were
differences between H&Y, Schwab and England ADL, PPS
Occulomotor and Cerebellar scores between clinical groups.
Pairwise comparisons were performed using Dunn’s (1964)
procedure with a Bonferroni correction for multiple comparisons.
Image Analysis. Whole-brain statistical analyses were per-
formed using Randomise v2.1 (FSL). Differences in FA and MD
between groups were assessed using a two-sample t test to compare
FA and MD values. Clinical groups were first compared with a
healthy control population, and then further compared to each
other. Additional analyses were run on all subjects as a single
group to assess associations between FA and MD values and
measures of disease severity (H Schwab and England ADL;
UDRS-III), PPS cerebellar and occulomotor scores and cognition
(MMSE; DRS).
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Age and gender were de-meaned before analysis and used as
covariates of no-interest within the voxel-based analysis. Thresh-
old-free cluster enhancement (TFCE) was used in all statistical
comparisons to correct for multiple comparisons across space; a
non-parametric permutation test was used, in which group
membership was permuted 5000 times to generate a null
distribution for each contrast. Due to the number of statistical
tests carried out an additional Bonferroni correction for multiple
comparisons was applied dividing the alpha value by the number
of tests each data set was included in. To localize significant voxel
effects, contrast maps were subdivided according to the 48 regions
of the JHU-ICBM-DTI-81 white matter atlas [35], allowing
identification of regions of significance and peak voxels within
clusters.
Results
Demographic and clinical variables
Diagnostic groups did not differ significantly in age, gender or
disease duration in one-way ANOVA analyses. However, post hoc
t-tests showed that the PSP group is significantly older than the
MSA (p = 0.007) and HC (p = 0.048) groups. The PD group
scored lower than the MSA and PSP groups on measures of
disease severity; H&Y (p#0.001), Schwab and England ADL (p#
0.01) and UPDRS III (p#0.001). The MSA group had more
severe cerebellar dysfunction (p#0.05) than the other two clinical
groups, while the PSP group had more severe occulomotor
dysfunction (p#0.001) and greater cognitive impairment; MMSE
(p#0.001) and DRS (p#0.001) (Table 1).
PD, MSA and PSP versus healthy controls
First, the white matter maps of each clinical group (PD, MSA,
PSP) were compared individually with the maps of age-matched
healthy control subjects.
PSP. These comparisons revealed regions of reduced FA in
PSP in the corpus callosum, anterior and superior corona radiata,
superior longitudinal fasciculus/arcuate, and corticospinal tract
bilaterally as well as the left posterior corona radiata (Figure 1;
Table 2). Regions of increased MD were found in the PSP group
in the corpus callosum, superior corona radiata, anterior thalamic
radiation, superior cerebellar peduncle, medial lemniscus, cerebral
peduncle and posterior limb of the internal capsule bilaterally
(Figure 1; Table 3).
MSA. MSA patients showed increased MD in the corticospi-
nal tract, middle and inferior cerebellar peduncles, and medial
lemniscus (Figure 2; Table 3).
PD. There were no significant differences between the PD
patients and healthy controls.
All results are Bonferroni corrected (corrected alpha = 0.0167).
Clinical group comparisons
PSP vs PD. Reduced FA was identified in the PSP group
when compared to PD in the corpus callosum, corona radiata,
corticospinal tract, anterior thalamic radiation, superior cerebellar
peduncle, external capsule, retrolenticular and anterior limb of the
internal capsule bilaterally, as well as the right superior
longitudinal fasciculus, left posterior limb of the internal capsule
and the right posterior thalamic radiation (Figure 1; Table 2).
Increased MD was also seen in PSP compared to PD, affecting the
corpus callosum, corona radiata, superior cerebellar peduncles,
anterior thalamic radiation, superior longitudinal fasciculus,
medial lemniscus, cerebral peduncle, posterior and anterior limbs
of the internal capsule and the external capsule bilaterally
(Figure 1; Table 3).
MSA vs PD. When compared to PD the MSA group
displayed reduced FA in the body of the corpus callosum, anterior
corona radiata, corticospinal tract, middle and inferior cerebellar
peduncles, medial lemniscus, and posterior limb of the internal
Table 1. Demographic and clinical data of control subjects and patients with PD, MSA and PSP.
Control (n =17) PD (n=14) MSA (n=16) PSP (n =16) P-value
Age, mean (SD) 63.9 (8.4) 64.7 (6.9) 62.3 (7.3) 69.2 (6.2) 0.056
Sex, M:F 9:8 7:7 8:8 6:10 NA
Disease duration,
mean (SD)
NA 6.6 (2.0) 5.1 (2.7) 5.2 (2.5) 0.181
H&Y* median
score (range)
NA 2.5 (2.0–3.0) 3.0 (2.5–5.0) 4.0 (3.0–4.0) ,0.001
Schwab and England
ADL* median
score (range)
NA 90% (80–100%) 60% (40–80%) 45% (20–80%) ,0.01
UPDRS III,
*mean +/2 SD (range)
NA 21.8+/29.6 (5–38) 37.6+/213.5 (12–62) 35.9+/26.6 (24–47) ,0.001
Occulomotor Score,
{median (range)
NA 0 (0–3) 1.5 (0–5) 16 (7–20) ,0.001
Cerebellar Score,
{median (range)
NA 0 (0–2) 7.5 (0–13) 2 (0–6) ,0.05
MMSE, mean (SD) 29 (1) 29.5 (1.1) 28 (2.7) 26 (2.7) ,0.001
DRS, mean (SD) 140 (3.4) 140 (2.9) 135.4 (8.9) 126 (10.2) ,0.001
*For patients taking levodopa drug treatment, scores given in the ‘on’ state.
{From Parkinson’s Plus Scale (Cerebellar Score, maximum 24; Occulomotor Score, maximum 21).
MSA=multiple systems atrophy; PSP = progressive supranuclear palsy; PD= Parkinson’s disease; MSA-P =multiple system atrophy parkinsonian variant; MSA-
C=multiple system atrophy cerebellar variant; H&Y=Hoehn and Yahr; ADL = activities of daily living; UPDRS III = Unified Parkinson Disease Rating Scale–part III;
MMSE =Mini Mental State Examination; DRS =Mattis Dementia Rating Scale.
doi:10.1371/journal.pone.0112638.t001
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capsule bilaterally, as well as the left anterior limb of the internal
capsule and left anterior thalamic radiation (Figure 2; Table 2).
Increased MD was found in the superior corona radiata,
corticospinal tract, superior, middle and inferior cerebellar
peduncles, posterior limb of the internal capsule, cerebral
peduncle and the external capsule bilaterally (Figure 2; Table 3).
PSP vs MSA. The PSP group showed increased MD when
compared to MSA in the anterior thalamic radiation and superior
cerebellar peduncles (Figure 1; Table 2).
Table 2. White matter regions of fractional anisotropy changes between PSP, MSA, PD and HC.
Region Coordinates PSP,HC PSP,PD MSA,PD
X Y Z P-value P-value P-value
Corpus callosum
Genu 4 27 0 0.0008 0.0002
Body 1 221 23 0.0006 0.0002 0.0106
Splenium 218 247 27 0.0008 0.0002
Corona Radiata
Left anterior 217 22 29 0.0011 0.0004 0.0166
Right anterior 18 16 29 0.0006 0.0002 0.0124
Left superior 218 11 33 0.0008 0.0004
Right superior 19 12 33 0.0006 0.0002
Left posterior 219 233 33 0.0008 0.0023
Right posterior 29 257 20 0.0072
Corticospinal
Right 20 231 50 0.0008 0.0006 0.0032
Left 26 255 220 0.0008 0.0092 0.0032
Longitudinal fasciculus
Left superior 236 231 34 0.0155
Right superior 39 26 30 0.0004 0.0006
Thalamic radiation
Right anterior 6 213 14 0.0036
Left anterior 24 214 14 0.0036 0.0096
Cerebellar peduncle
Left superior 27 245 229 0.0038
Right superior 7 47 232 0.0038
Middle 14 235 230 0.0021
Left inferior 211 246 230 0.0021
Right inferior 13 246 230 0.0021
Pontine crossing tract 2 231 230 0.0017
Lemniscus
Left medial 26 238 230 0.0025
Right medial 6 237 230 0.0025
External Capsule
Left 228 14 0 0.0062
Right 31 12 0 0.0072
Internal Capsule
Left retrolenticular 229 221 0 0.0104
Right retrolenticular 38 228 0 0.0068
Left posterior limb 220 214 0 0.0072 0.0077
Right posterior limb 19 210 0 0.0196
Left anterior limb 210 5 0 0.0072 0.0098
Right anterior limb 10 5 0 0.0134
Thalamic Radiation
Right posterior 30 260 0 0.0068
All results reported at p,0.05, TFCE and Bonferroni corrected (corrected alpha = 0.0167).
doi:10.1371/journal.pone.0112638.t002
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Figure 1. White matter maps showing regions of significant decreased fractional anisotropy and increased mean diffusivity in PSP
patients when compared to healthy controls, PD and MSA (Bonferroni corrected alpha=0.0167). Background image corresponds to the
mean fractional anisotropy image of all subjects in standard MNI152 space (radiological view). Fractional anisotropy white matter skeleton is
represented by green voxels. Blue voxels represent regions of decreased FA and yellow voxels represent regions of increased MD in the PSP group.
doi:10.1371/journal.pone.0112638.g001
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There were no regions in which PD showed significantly
reduced FA or decreased MD compared to either MSA or PSP.
All results passed bonferroni correction (corrected alpha = 0.0167).
Relationship between FA and MD values and clinical
variables
Measures of disease severity showed significant correlation with
MD values after Bonferroni correction. Disease severity as
measured by the Schwab and England ADL correlated negatively
with MD values in all main white matter tracts that showed
changes in this study (see Table 2 and 3) with a right lateralisation
of the corona radiata, corpus callosum and superior longitudinal
fasciculus (Figure 3). MD values in the middle cerebellar
peduncles also correlated positively with scores on the H&Y scale
of disease severity (Figure 3).
Radial and Axial Diffusivity
As requested by one of the reviewers additional analyses were
undertaken to assess group differences in radial and axial
diffusivity. As these measures were not part of the hypothesis for
this study we have included these results (see Table S1 and S2).
Discussion
To our knowledge this is the first study to investigate DTI
indices consistent with white matter microstructural properties
using a whole-brain automated technique to directly compare PD,
MSA, PSP and healthy control subjects. We demonstrate changes
in FA and MD measures that are consistent with white matter
tract degeneration in PSP encompassing all of the main white
matter tracts including the corpus callosum, superior longitudinal
fasciculus, superior cerebellar peduncles and cingulum, in line with
recent reports [12–17,36]. These results support the work of
Agosta and colleagues, whilst also identifying additional regions
that may be implicated in the disease process by using an
exploratory whole-brain approach that does not rely on a priori
regions of interest. Other regions showing changes in PSP included
the corona radiata, thalamic radiation, medial lemniscus, cerebral
peduncle, internal capsule and the external capsule. In MSA
changes reflecting white matter tract degeneration were observed
in the middle and inferior cerebellar peduncle, corticospinal tract,
lemniscus, cerebral peduncle, left posterior limb of the internal
capsule and left external capsule. Consistent with previous studies,
white matter was found to be intact in PD [20,37–39].
Of particular interest is the superior cerebellar peduncles in PSP
which showed significant changes that may be reflective of
neurodegeneration. In contrast, patients with MSA displayed
significant changes in the middle and inferior cerebellar peduncles
compared to healthy controls and in the superior, middle and
inferior cerebellar peduncles when compared with PD. These
results are in line with a previous study that has reported the ability
to differentiate between patients with PD, MSA and PSP based on
diffusion measures in the middle cerebellar peduncles [9] – a
region that appears to be particularly affected in MSA. In this
study, MD values across the cerebellar peduncle also correlated
with patients H&Y and Schwab and England ADL scores;
measures of disease severity, which may mean that degeneration
in this region could be used to assess disease progression and that
cerebellar peduncle diffusion measures along with a network of
other regions of high significance such as the corpus callosum and
corona radiata may have the potential to be used to discriminate
between MSA and PSP. Furthermore, these results confirm that
degeneration of these tracts does not occur in PD.
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Interestingly, superior cerebellar peduncles abnormalities in
PSP relative to PD, MSA and control subjects were found only for
MD value, while reduced FA identified greater changes in the left
peduncle relative to PD. This discrepancy between fractional
anisotropy and mean diffusivity results could be due to differences
in fiber architecture between subjects leading to increased
variability of fractional anisotropy across groups – fiber architec-
ture is a major determinant of anisotropy in healthy brains [40].
Mean diffusivity may provide a more direct measure of neuronal
integrity because it is believed to be less affected by the fiber
architecture or its structural organisation.
Significantly reduced FA and MD were observed in PSP in the
genu, body and splenium of the corpus callosum. These results are
more widespread than in previous studies that have reported only
partial involvement of the corpus callosum [12,14,36,41]. The
fibres of the genu of the corpus callosum provide connections to
the premotor and supplementary motor areas of the superior
frontal gyrus – regions of grey matter that have been previously
implicated in the disease [12,42,43] whilst the splenium of the
Figure 2. White matter maps showing regions of significant decreased fractional anisotropy and increased mean diffusivity in MSA
patients when compared to healthy controls and PD (Bonferroni corrected alpha=0.0167). Background image corresponds to the mean
fractional anisotropy image of all subjects in standard MNI152 space (radiological view). Fractional anisotropy white matter skeleton is represented by
green voxels. Blue voxels represent regions of decreased FA and yellow voxels represent regions of increased MD in the PSP group.
doi:10.1371/journal.pone.0112638.g002
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corpus callosum communicates somatosensory information be-
tween the parietal lobe and visual centre of the occipital lobe. FA
and MD values in the corpus callosum did not correlate with any
clinical variables. It could be that loss of integrity in these white
matter tracts is a result of Wallerian degeneration, a secondary
degeneration of axons following cortical grey matter atrophy in
regions that have been found to be related to clinical symptoms
and severity.
An alternative explanation to Wallerian degeneration could be
activated microglia or tau deposition causing changes to the
microstructural properties of these white matter tracts. The
pattern of degeneration of white matter tracts in PSP seen in
this study is consistent with the pattern of activated microglia
found in a previous study [44]. The activation of microglia is a
reactive response to pathology [45] and so is likely to indicate
where pathology exists but not the cause of it. The presence of
microglia in white matter tracts has been shown to correlate with
tau burden in the cerebral peduncle and internal capsule, but not
the superior cerebellar peduncle where microglial presence was
higher. Thus in some regions microglia may become active in
response to tau related pathology, whilst in others microgliosis may
be related to degeneration that is not associated with tau
pathology, but another cause of initial degeneration, with
microgliosis leading to further tissue pathology [46]. Similarly, in
MSA, both activated microglia and glial cytoplasmic inclusion
(GCI) are present in affected white matter tracts [44,47,48].
Further pathological studies are required to understand the impact
of protein dysfunction, microgliosis and Wallerian degeneration on
white matter integrity in these populations.
This study additionally identified lateralisation of FA changes in
regions including the left posterior corona radiata, right superior
longitudinal fasciculus and right posterior thalamic radiation in
PSP and in the left anterior thalamic radiation, left anterior limb of
the internal capsule in MSA patients. Hemispheric lateralisation
has not been well studied in these patient samples and has not
been reported in previous studies of this nature, thus these results
will need to be verified in a larger sample size to ensure that this
lateralisation is not an artefact.
Our study has a number of strengths. This is the first study to
explore differences and similarities of DTI indices that are
indicative of white matter tract degeneration in PD, MSA and
PSP populations in a single study. Secondly, this is the first study to
apply a whole-brain automated technique in these populations,
avoiding the use of a priori defined ROIs. TBSS offers several
other advantages over other methods, for example it removes the
need for spatial smoothing and minimises the methodological
pitfalls caused by misalignment and misregistration, consequently
improving the sensitivity and interpretability of findings. The main
limitation of this study is the sample size for each clinical group,
the statistical power of the study would be increased with larger
group sizes. In addition, results may have been affected by the
slightly older age of the PSP patients, thus age was included as a
nuisance factor in all analyses to account for this difference. It
would also have been beneficial to run a battery of neuropsycho-
logical tests on all subjects to rule out confounding effects due to
other disorders or conditions. Due to the inclusion of a series of
statistical tests with the four groups, a Bonferroni correction was
applied which is likely to have reduced the power of the results.
Finally, in this study both subtypes MSA-C and MSA-P patients
were included as a single MSA group, it is possible that there are
subtle pathological differences between these groups, thus in future
it would be interesting to look at both of these subtypes as separate
groups.
It is clear from this study that in the established disease state
PSP patients have profound and widespread white matter
alterations. Similarly, MSA patients also display white matter
changes in the later stages of the disease. Despite PD patients
having longer mean disease duration than MSA and PSP, they
scored significantly lower on measures of disease severity and
displayed unaffected white matter. This evidence, along with
positive correlations between disease severity and white matter
changes, provides evidence for slower neurodegeneration along
with slower symptom progression [1] in PD compared to other
Parkinsonian syndromes. This study provides a comprehensive
characterisation of white matter alterations in MSA and PSP that
may be used to identify regions of particular interest in future
studies assessing early stage disease and may in future aid in the
identification of an in vivo biomarker. In conclusion, this work
provides evidence for widespread changes in FA and MD that are
consistent with white matter neurodegeneration in both MSA and
PSP patients, whilst white matter remains preserved in PD. These
disruptions are particularly evident in the cerebellar peduncles,
supratentorial regions and association fibers.
Figure 3. White matter maps showing regions of significant
correlation between mean diffusivity and measures of disease
severity (Bonferroni corrected alpha=0.0167). Top row coronal
view, bottom row axial view. Background image corresponds to the
mean fractional anisotropy image of all subjects in standard MNI152
space (radiological view). Fractional anisotropy white matter skeleton is
represented by green voxels. Blue voxels represent regions of
decreased FA and yellow voxels represent regions of increased MD in
the PSP group.
doi:10.1371/journal.pone.0112638.g003
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Supporting Information
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reported at p,0.05, TFCE corrected.
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